Home/Filings/4/0001127602-24-017309
4//SEC Filing

LaPlume Joseph W 4

Accession 0001127602-24-017309

CIK 0001100682other

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 4:37 PM ET

Size

7.1 KB

Accession

0001127602-24-017309

Insider Transaction Report

Form 4
Period: 2024-05-31
LaPlume Joseph W
EVP, Corp Strategy & Develop
Transactions
  • Award

    Common Stock

    2024-05-31+2,11124,612 total
  • Award

    Stock Options (Right to Buy)

    2024-05-31$208.44/sh+4,797$999,8874,797 total
    Exercise: $208.44From: 2025-05-31Exp: 2034-05-31Common Stock (4,797 underlying)
Footnotes (2)
  • [F1]Unvested restricted stock units vest as follows: 527 on May 31, 2025, 528 on May 31, 2026, 528 on May 31, 2027, and 528 on May 31, 2028.
  • [F2]Stock options vest as follows: 1,199 on May 31, 2025, 1,199 on May 31, 2026, 1,199 on May 31, 2027, and 1,200 on May 31, 2028.

Issuer

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CIK 0001100682

Entity typeother

Related Parties

1
  • filerCIK 0001767215

Filing Metadata

Form type
4
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:37 PM ET
Size
7.1 KB